Key facts
| Price (PPV) | 418 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | lidocaïne basecétrimonium bromure |
| Class | Anesthetics |
| ATC code | N01BB02 |
| Manufacturer | STERIPHARMA |
| Presentation | Flacon pulvérisateur 36 g |
| Nature | Médicament |
| Hospital price | 278 MAD |
| Data collected on | 9/8/2026 |
Indications
· Ce médicament est indiqué dans l’anesthésie locale de surface de la cavité buccale chez l’adulte, l’adolescent et l’enfant lors des interventions suivantes : o Anesthésie d’infiltration, o Taille et pose de couronnes et pilier de bridge, o Détartrage juxta-gingival et sous-gingival. · Abolition du réflexe nauséeux lors d’une prise d'empreintes. Ce médicament est indiqué chez les adultes et chez les enfants et adolescents âgés de 6 à 18 ans.
Find an open pharmacy
On-call pharmacies near you
About Xylonor 15 g / 0.15 g
Xylonor 15 g / 0.15 g belongs to the anesthetics therapeutic class. In Morocco, this drug is marketed by STERIPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Xylonor 15 g / 0.15 g, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Xylonor 15 g / 0.15 g
Answers to common questions from Moroccan patients about this drug.